Skip to main content

ADVERTISEMENT

Venous

Purpose: Small branching veins that arise from the outflow of arteriovenous fistulas (AVFs) are seen during fistulograms performed to evaluate for poor function. The mechanism leading to ...
01/21/2022
Purpose: Ultrasound and digital subtraction angiography are the standard of care for evaluation of hemodialysis (HD) arteriovenous access. However, in patients with a severe allergy to io...
01/20/2022
Meeting Exclusives
02/24/2020
Jafar Golzarian, MD, and Constantino Peña, MD, spoke in a session dedicated to pulmonary embolism (PE) and filters.
Jafar Golzarian, MD, and Constantino Peña, MD, spoke in a session dedicated to pulmonary embolism (PE) and filters.
Jafar Golzarian, MD, and...
02/24/2020
Vascular Disease Management
Meeting Exclusives
02/10/2020
Two-year findings from the VIRTUS trial of the VICI venous stent (Boston Scientific) showed a primary patency rate of 79.4%. As has been seen in other trials, primary patency was higher in non-thrombotic lesions (94.6%) as compared to...
Two-year findings from the VIRTUS trial of the VICI venous stent (Boston Scientific) showed a primary patency rate of 79.4%. As has been seen in other trials, primary patency was higher in non-thrombotic lesions (94.6%) as compared to...
Two-year findings from the...
02/10/2020
Vascular Disease Management
02/07/2020
Endovenous stenting to relieve chronic venous disease secondary to post-thrombotic or non-thrombotic iliac vein obstruction is becoming increasingly established.
Endovenous stenting to relieve chronic venous disease secondary to post-thrombotic or non-thrombotic iliac vein obstruction is becoming increasingly established.
Endovenous stenting to relieve...
02/07/2020
Vascular Disease Management
Endo AV Access: New Data Emerge on the WavelinQ System
Meeting Exclusives
01/28/2020
Rob Jones, MD, presented a first-time data release from the prospective, multicenter study to evaluate the WavelinQ endoAVF system (BD), used to create an endovascular arteriovenous fistula (endoAVF) for patients requiring vascular access for...
Rob Jones, MD, presented a first-time data release from the prospective, multicenter study to evaluate the WavelinQ endoAVF system (BD), used to create an endovascular arteriovenous fistula (endoAVF) for patients requiring vascular access for...
Rob Jones, MD, presented a...
01/28/2020
Vascular Disease Management
IN.PACT AV Access Meets Endpoints in Six-Month Results; Follow-Up Extended to 5 Years
01/24/2020
Hollywood, FL (January 23, 2020) -- Robert Lookstein, MD, presented the 6-month results of the IN.PACT AV access trial at the International Symposium on Endovascular Therapy (ISET). This study is the second pivotal drug-coated balloon (DCB)...
Hollywood, FL (January 23, 2020) -- Robert Lookstein, MD, presented the 6-month results of the IN.PACT AV access trial at the International Symposium on Endovascular Therapy (ISET). This study is the second pivotal drug-coated balloon (DCB)...
Hollywood, FL (January 23, 2020)...
01/24/2020
Vascular Disease Management
01/24/2020
Enrollment is completed and baseline demographics available for the ABRE IDE study of the ABRE Venous Stent (Medtronic), according to principal instigator Erin Murphy, MD, director of the venous and lymphatic program at Carolinas HealthCare...
Enrollment is completed and baseline demographics available for the ABRE IDE study of the ABRE Venous Stent (Medtronic), according to principal instigator Erin Murphy, MD, director of the venous and lymphatic program at Carolinas HealthCare...
Enrollment is completed and...
01/24/2020
Vascular Disease Management
01/23/2020
At two years, primary patency was 84.3% with the Venovo venous stent (BD) in iliac and femoral vein obstructions, with the rates of freedom from target lesion revascularization (TLR) and target vessel revascularization (TVR) both clocking in...
At two years, primary patency was 84.3% with the Venovo venous stent (BD) in iliac and femoral vein obstructions, with the rates of freedom from target lesion revascularization (TLR) and target vessel revascularization (TVR) both clocking in...
At two years, primary patency...
01/23/2020
Vascular Disease Management